Viewport 05 · GTM Priority Quadrant

Amazon optimizes today. Target Plus is the beachhead. CVS, Walgreens, Walmart are an eighteen-month build.

Six channels plotted by AXIV's readiness today against the channel's upside. Genexa's four-year arc to 60,000 stores is the canonical path for a same-actives challenger entering the same shelf. The realistic mix today is one channel.

6 channels · readiness × upside
arc = Genexa precedent (2020–2026)
Open / reachable now Gated · medium-term Closed until rebrand Genexa precedent path (2020 → 2026)

What the quadrant shows

One channel is live. The rest need a rebrand to unlock.

Amazon is the only channel where AXIV operates today. Nineteen ASINs, roughly 12,500 visible ratings on the four lead SKUs, through the OTC ungating gate. Amazon sits high-right on the quadrant. High readiness because AXIV is already there. High upside because Brand Registry, Brand Store, A+ Content, and Sponsored Brands are reachable inside a quarter without a finished rebrand. The optimization work is execution hygiene, listing-copy rewrite, the DM Max bottle-cap defect fix, and the AXIV-versus-AXIM legacy-slug cleanup.

Target Plus Marketplace is the only brick-and-mortar-adjacent channel reachable inside twelve months. It is a 3P beachhead. Lower gate than 1P shelf, no EDI buildout, faster to velocity. The Genexa precedent supports the pattern. Genexa entered Target in 2020, expanded to 500 stores under Target Clean qualification in 2024, and added baby-aisle placement in 2026. Target rewards clean and transparency-led brand builds with sequential shelf expansion. AXIV cannot enter Target Clean today because the axiv.live surface does not surface a clean narrative. Packaging redesign is the gate.

CVS, Walgreens, and Walmart 1P are eighteen-to-thirty-six-month moves. Each carries a chain-specific gate. CVS supplier-diversity lanes are closed to Argentine ownership and the compare-to claim register collides with CVS Health's own private-label register. Walgreens routes through WBA Global Sourcing, the international-supplier lane, and its legal team is sensitized to cold and flu claim language since the 2012 FTC Wal-Born settlement. Walmart's branded-shelf path is hard for foreign-owned challengers; the Walmart International Sourcing lane is open but is a private-brand path (Virixene supplying Equate or a new Walmart label), not a branded-shelf path. Independent and Hispanic-market pharmacy is the one place where the Argentine-pharma heritage is an asset rather than a closed lane. Bodegas, Hispanic-market chains, and Hispanic-owned independent pharmacies are the natural beachhead for the Latin-American-pharma heritage story.

← Previous viewport

The questions no brand is answering

Companion read →

The full editorial brief